BIIB - Biogen granted EU backing for ALS therapy
2024-02-23 07:59:52 ET
More on Biogen
- Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade)
- Biogen Inc. (BIIB) Q4 2023 Earnings Call Transcript
- Biogen Inc. 2023 Q4 - Results - Earnings Call Presentation
- DOJ issues subpoena for info on Biogen's foreign operations
- Wells Fargo downgrades Biogen to equal weight, cites Skyclarys sales